CytoDyn Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate
CytoDyn Inc. (CYDY) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate of 120.29% for the 12-month period ending 2026-05-31, per its 10-K filed 2026-08-31.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate · last filed 2026-08-31
- CytoDyn Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, weighted average volatility rate for fiscal 2026 was 120.29%, a 5.30% decline from fiscal 2025.
- CytoDyn Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, weighted average volatility rate for fiscal 2025 was 127.02%.
- CytoDyn Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, weighted average volatility rate for fiscal 2023 was 107.06%, a 2.07% increase from fiscal 2022.
- CytoDyn Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, weighted average volatility rate for fiscal 2022 was 104.89%, a 23.60% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate 12 month |
|---|---|
| 2026-05-31 | 120.29% 10-K · filed 2026-08-31 |
| 2025-05-31 | 127.02% 10-K · filed 2026-08-31 |
| 2024-05-31 | 112.24% S-1 · filed 2026-04-22 |
| 2023-05-31 | 107.06% 10-K · filed 2024-08-15 |
| 2022-05-31 | 104.89% 10-K · filed 2023-09-14 |
| 2021-05-31 | 84.86% 10-K · filed 2022-08-15 |
| 2020-05-31 | 52.29% 10-K · filed 2022-08-15 |